$187 Million is the total value of Alistair Capital Management, L.L.C.'s 17 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VOYA | VOYA FINL INC | $5,083,000 | +7.6% | 130,000 | 0.0% | 2.72% | -2.0% | |
| MIG | MEADOWBROOK INS GROUP INC | $2,979,000 | -18.6% | 509,200 | 0.0% | 1.60% | -25.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMTRUST FINL SVCS INC | 5 | Q4 2014 | 100.0% |
| CABELAS INC | 4 | Q3 2014 | 12.6% |
| TESSERA TECHNOLOGIES INC | 4 | Q3 2014 | 4.4% |
| TIVO INC | 4 | Q3 2014 | 4.0% |
| PICO HLDGS INC | 4 | Q3 2014 | 3.8% |
| DIGITAL RIV INC | 4 | Q3 2014 | 3.1% |
| WPX ENERGY INC | 4 | Q3 2014 | 3.4% |
| ORTHOFIX INTL N V | 4 | Q3 2014 | 2.7% |
| MEADOWBROOK INS GROUP INC | 4 | Q3 2014 | 2.2% |
| TAL INTL GROUP INC | 3 | Q2 2014 | 17.9% |
View Alistair Capital Management, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cardiome Pharma CorpSold out | February 20, 2015 | 0 | 0.0% |
| MAXYGEN INC | February 13, 2013 | 247,852 | 0.9% |
View Alistair Capital Management, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2015-11-16 |
| 13F-NT | 2015-08-14 |
| 13F-NT | 2015-05-15 |
| SC 13G/A | 2015-02-20 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
| 13F-HR | 2014-05-15 |
| 13F-HR | 2014-02-13 |
| SC 13G/A | 2014-02-11 |
View Alistair Capital Management, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.